Global /Hong Kong /Healthcare /Drug Manufacturers - General /455

Tianda Pharmaceuticals Ltd.

455

• SHEK: 455 • Delayed

0.0980HKD 1%

0.0125 USD

As of 6 June 2026, Tianda Pharmaceuticals Ltd. has a market cap of $26.89M USD, ranking #35012 globally and #946 in Hong Kong. It ranks #3159 in the Healthcare sector, and #1067 in the Drug Manufacturers - General industry.

Global Rank

35012

Country Rank

946

Sector Rank

3159

Industry Rank

1067

Key Stats

Market Cap

$26.89MUSD

210.7M HKD

Enterprise Value

$35.51MUSD

278.27M HKD

Revenue (TTM)

$41.22MUSD

322.95M HKD

EBITDA (TTM)

-$3.11MUSD

-24.41M HKD

Net Income (TTM)

-$8.93MUSD

-70.0M HKD

EBITDA Margin

-7.6%

Profit Margin

-22%

PS Ratio

0.7

PB Ratio

0.5

Company Profile

Country (HQ)

Hong Kong

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Wen Quan Fang open_in_new

Employees

613

Founded

1992

Website

tiandapharma.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1%	1%	1%	-10%	-28%	-24%	-46%	-60%	-49%

News

Markets

Exchange	Ticker	Price	Quotes
Hong Kong Stock Exchange (SHEK / HKEX) MIC: XHKG PRIMARY	455 天大藥業有限公司 ISIN: KYG887471038 Shares Out.: Shares Outstanding: 2.15B¹ Shares Float: 442.328M² TV: TradingView: HKEX: 455 SA: Stock Analysis: HKG: 0455 YF: Yahoo Finance: 0455.HK GF: Google Finance: HKG: 0455 BA: Barron's: 455 MS: Morningstar: XHKG: 00455	0.0980 HKD	TV: TradingView: HKEX: 455 SA: Stock Analysis: HKG: 0455 YF: Yahoo Finance: 0455.HK GF: Google Finance: HKG: 0455 BA: Barron's: 455 MS: Morningstar: XHKG: 00455

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Tianda Pharmaceuticals Ltd.

Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It operates through the Chinese Medicine, Pharmaceuticals and Medical Technologies, and Medical and Healthcare Services segments. The company offers Chinese herbal medicine, Chinese medicine decoction pieces, Chinese medicine products, and Chinese medicine clinical services. It also produces pharmaceutical products focusing on cardiovascular and cerebrovascular chronic diseases, respiratory infections, and pediatric diseases. In addition, the company trades agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.

Similar Companies

Industry: Drug Manufacturers - General (Hong Kong)

Name	Market Cap (USD) diff.	PE	Country
Regencell Bioscience Holdings Ltd. NASDAQ: RGC	$14.32B 53K%	-	Hong Kong
Sino Biopharmaceutical Ltd. SHEK: 1177	$12.45B 97.51B HKD 46K%	37.8	Hong Kong
InSilico Medicine Cayman TopCo SHEK: 3696	$4.7B 36.81B HKD 17K%	-	Hong Kong
China Resources Pharmaceutical Group Ltd. SHEK: 3320	$4.2B 32.92B HKD 16K%	7.3	Hong Kong
Grand Pharmaceutical Group Ltd. SHEK: 512	$2.86B 22.45B HKD 11K%	18.1	Hong Kong
The United Laboratories International Holdings Ltd. SHEK: 3933	$2.4B 18.78B HKD 9K%	7.7	Hong Kong

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 3M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 2M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 1M%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 1M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 1M%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 1M%	20.5	Switzerland

chevron_leftBack